Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)

    NEXT STORY
    RenovaCare Appoints Alan L. Rubino as President and CEO
    PREV STORY
    BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Oral Proteins and Peptides Market 2018-2030 – Current Market Landscape of Orally Administrable Protein / Peptide-Based Therapeutics

    Dublin, Aug. 22, 2018 (GLOBE NEWSWIRE) -- The "Oral Proteins and Peptides Market (3rd ...

    author_avatar
    NASDAQ Market News

    Anthera Pharmaceuticals Provides Business Update and Reports 2016 Third Quarter Financial Results

    Blisibimod topline data from the Phase 3 CHABLIS-SC1 Study in severe lupus patients is ...

    author_avatar
    NASDAQ Market News

    Orion and Amgen to collaborate on the commercialisation of AMGEVITA® (biosimilar adalimumab) in Finland

    Orion Corporation                              Press Release 24 October 2018 at 12.30 p.m. EESTOrion and Amgen to ...

    author_avatar
    NASDAQ Market News